1. Home
  2. LPTH vs PHAR Comparison

LPTH vs PHAR Comparison

Compare LPTH & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightPath Technologies Inc.

LPTH

LightPath Technologies Inc.

HOLD

Current Price

$10.10

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$11.16

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPTH
PHAR
Founded
1985
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
LPTH
PHAR
Price
$10.10
$11.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$13.33
$38.33
AVG Volume (30 Days)
3.3M
20.7K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,202,630.00
N/A
Revenue This Year
$83.04
$10.04
Revenue Next Year
$24.83
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
17.26
N/A
52 Week Low
$5.75
$9.62
52 Week High
$18.94
$21.34

Technical Indicators

Market Signals
Indicator
LPTH
PHAR
Relative Strength Index (RSI) 41.53 42.27
Support Level $9.60 $11.03
Resistance Level $13.21 $13.51
Average True Range (ATR) 0.89 0.35
MACD -0.32 -0.01
Stochastic Oscillator 21.85 4.72

Price Performance

Historical Comparison
LPTH
PHAR

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: